Korean drugmakers facing ‘survival game’

Published: 2009-09-01 06:57:00

Updated: 2009-09-01 06:57:00

From the local pharmaceutical companies to wholesalers, worries have arisen that the country might lose its leadership in the face of the government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug purchase in the National As...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK